Microsoft faces a paradox: thriving financially, yet undergoing significant layoffs. Satya Nadella acknowledged the "enigma ...

Cigna's earnings report is coming soon, so investors are on edge. Will Cigna surpass Wall Street's estimates, or will it fall ...

Thermo Fisher Scientific Inc. just made headlines with its hefty $17.6 billion acquisition of PPD, Inc., aiming to bolster ...

UBS remains bullish on Merck, reiterating its Buy rating with a $105 price target. This optimism follows Merck's planned $10 ...

Freemont Management S.A. just made a splash, investing $2.95 million in Salesforce. But they aren't the only ones shaking ...

Analysts predict that Starbucks' upcoming quarterly earnings will drop to $0.64 per share. This represents a 31.2% decrease ...

In a turbulent market, Blackstone Inc showcased a robust Q2 2025, with a sharp increase in assets under management (AUM) and ...

Eli Lilly's Alzheimer's drug, donanemab (Kisqali), just got a thumbs-up from the European Medicines Agency's (EMA) expert ...

UBS Group recently elevated its price target on RTX from $166.00 to $177.00, signaling a robust 14.05% potential upside, ...

Seaport Res Ptn has updated its Q3 earnings forecast for Morgan Stanley, pushing the EPS estimate from $2.03 to $2.09. This ...

The U.S. railroad sector is buzzing with the news of Union Pacific and Norfolk Southern's potential $200 billion merger, ...

In the first quarter, Kathleen S. Wright Associates Inc. slashed its stake in Johnson & Johnson by a hefty 21.1%, unloading 1 ...